Definium Therapeutics, Inc.

DFTX·NASDAQ·$22.88Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2507/31/25

Disclosures

8-KCurrent report09/14/26 8-KCurrent report09/08/26 8-KCurrent report08/12/26 8-KCurrent report08/06/26 8-KCurrent report06/24/26

Prospectuses and Registrations

424B5Prospectus supplement06/24/26 424B5Prospectus supplement06/22/26 S-8Registration of securities for employees06/16/26 424B5Prospectus supplement10/31/25 424B5Prospectus supplement10/29/25

Proxies

DEF 14ADefinitive proxy04/27/26 DEFA14AAdditional proxy materials04/27/26 DEF 14ADefinitive proxy04/23/25 DEFA14AAdditional proxy materials04/23/25 DEF 14ADefinitive proxy04/26/24

Ownership

Form 4Insider transaction09/29/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/29/26 Form 4Insider transaction09/29/26

Other

DD05/05/25 ARSAnnual report to shareholders04/23/25 EFFECTRequest for effectiveness04/29/24 ARSAnnual report to shareholders04/26/24 CORRESPCorrespondence with the SEC04/26/24